Bio
Joined MVM in 2002. Previously a member of the healthcare investment team at 3i. Prior to that, was an Engagement Manager with McKinsey & Company based in London and Mumbai. Member of the boards of Argenta Discovery Ltd, Healthcare Brands International Ltd, Heptares Therapeutics Ltd, PregLem SA, Serentis Ltd, and Vantia Therapeutics Ltd. Degree in Biochemistry from Oxford University and completed a PhD in Molecular Biology at Cambridge before going on to postdoctoral work in Paris.
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Syncona Investment Management Ltd |
||
|
Quell Therapeutics LtdDeveloper of engineered T regulatory cell therapies. |
||
|
MVM Life Science Partners LLPVenture capital firm which invests in technologies and products for the life science and healthcare markets |